Tải bản đầy đủ (.pdf) (38 trang)

Lạm dụng các loại ma túy mới: ý nghĩa lâm sàng

Bạn đang xem bản rút gọn của tài liệu. Xem và tải ngay bản đầy đủ của tài liệu tại đây (2.82 MB, 38 trang )

<span class='text_page_counter'>(1)</span><div class='page_container' data-page=1>

<b>Emerging Drugs of Abuse: </b>


<b>Clinical Implications </b>



<b>Scott Phillips, MD, FACP, FACMT, FAACT</b>
<b>Associate Medical Director</b>


</div>
<span class='text_page_counter'>(2)</span><div class='page_container' data-page=2>

“Synthetic” Drugs



 Drugs like Molly, MDMA, 2C-E, bath salts, tend


to be a small segment of drug use


 Present a problem because they rapidly change


</div>
<span class='text_page_counter'>(3)</span><div class='page_container' data-page=3>

History



 1990s: surge in use of


3,4-methylenedioxy-N-methylamphetamine (MDMA), rave drugs


 Many new derivatives available now


 Most contain little MDMA


 Amphetamine, DXM, BZP, etc.


 Next generation includes:


 Tryptamines


 Phenylethylamines



</div>
<span class='text_page_counter'>(4)</span><div class='page_container' data-page=4>

Tryptamines



 Re-emerged on drug scene


 Include DMT, 5-MeO-DIPT, 5-MeO-DMT,


and more


 Yakee plant, Foxy methoxy, alpha-O, O-DMS,


alpha and bufo toad secretions


 Similar to psilocybin, psilocin, and bufotenine


 Derivatives of tryptamine contain stimulant


</div>
<span class='text_page_counter'>(5)</span><div class='page_container' data-page=5></div>
<span class='text_page_counter'>(6)</span><div class='page_container' data-page=6>

Tryptamine Pharmacology



 Mechanism of action not fully elucidated
 Similar to classical hallucinogens like LSD


 Direct agonists at 5-HT<sub>2A</sub> and 5-HT<sub>1C</sub>


 Presentation includes


 Empathy


 Euphoria



 Visual/auditory hallucinations
 Tachycardia/HTN


 Confusion
 Seizures


</div>
<span class='text_page_counter'>(7)</span><div class='page_container' data-page=7>

Dimethyltryptamine (DMT)


 DMT discovered in


1960s


 “Businessman’s


lunch”


 DMT used in South


America for spiritual
and medicinal


purposes


 Available in various


</div>
<span class='text_page_counter'>(8)</span><div class='page_container' data-page=8>

Management of Tryptamine Toxicity



 Treatment


 Supportive care
 No antidotes



 Nice, quiet dark room


</div>
<span class='text_page_counter'>(9)</span><div class='page_container' data-page=9></div>
<span class='text_page_counter'>(10)</span><div class='page_container' data-page=10>

Phenylethylamines



 Newer designer analogues designated “2C”


series


 DOM: STP (Serenity, Tranquility, & Peace)
 Mescaline: Mesc, Buttons, Cactus


 2C-B: Nexus, Bromo, Bees, Venus
 2C-T-2: Triptasy or Beautiful


 2C-E: Europa, Eternity


 2C-T-7: Blue Mystic and 7th Heaven


</div>
<span class='text_page_counter'>(11)</span><div class='page_container' data-page=11>

Phenylethylamines



 Pharmacology similar to bath salts


 Affect dopamine, norepinephrine and serotonin


 Increase release of catecholamines and inhibit the


reuptake of them


 Ring substitutions increase affinity for 5-HT<sub>2</sub>



receptors


 Agonist properties at other 5-HT substypes


and α<sub>1</sub>-adrenergic receptor


</div>
<span class='text_page_counter'>(12)</span><div class='page_container' data-page=12></div>
<span class='text_page_counter'>(13)</span><div class='page_container' data-page=13>

Phenylethylamines


 Hallucinations


 Visual and auditory


 Euphoria
 Entactogen
 Tachycardia
 Paranoia
 Delirium
 Bruxism


 Violent behavior


 Refractory seizures


and serotonin toxicity
with 2C-I reported


 Recently in Seattle


 Death in 15 yo by



25i-NBOMe


 Fatal cardiac arrest


after 2C-E


 No literature on


</div>
<span class='text_page_counter'>(14)</span><div class='page_container' data-page=14>

Molly



 Highly purified form of MDMA


 Methylene-dioxy-methamphetamine


 Oftentimes contains very little MDMA


 Other drugs sold as Molly


 MDMA is neurotoxic even with a single dose


 Destroys 5-HT receptors and serotonergic neurons
 Long terms effects result in neuroendocrine


impairments to deficits in verbal memory and
reasoning


 Chronic psychosis responds poorly to traditional


therapy



</div>
<span class='text_page_counter'>(15)</span><div class='page_container' data-page=15>

Management


 In the ED


 Management largely supportive


 Benzodiazepines as indicated for sympathomimetic


symptoms


 Hyperthermia is what kills these patients
 Body temps of 111 degrees F


 Rapid cooling with ice and chilled saline fluids


</div>
<span class='text_page_counter'>(16)</span><div class='page_container' data-page=16></div>
<span class='text_page_counter'>(17)</span><div class='page_container' data-page=17>

“NMUO”



</div>
<span class='text_page_counter'>(18)</span><div class='page_container' data-page=18></div>
<span class='text_page_counter'>(19)</span><div class='page_container' data-page=19>

Opiate Prescribing



 Steady increase in opioid prescribing from 2006,


 Total # of Rx’s peaked in 2012 at >255 million and a rate of 81.3 Rx per 100
 The overall national opioid prescribing rate declined from 2012 to


2016


 In 2016, the Rx rate had fallen to the lowest in 10 years at 66.5 Rx per 100


 over 214 million total opioid prescriptions).


 However, in 2016, prescribing rates continue to remain very high in



areas across the country.


 In ¼ of U.S. counties, opioid Rx’s were dispensed for every


person.


 Opioid prescribing rate in 2016 was 66.5 prescriptions per 100


</div>
<span class='text_page_counter'>(20)</span><div class='page_container' data-page=20>

Fentanyl



 50-100 times > potent than Morphine


 50 times > than heroin


 1 kg can make 1 million tablets


 20-80 USD per tablet


</div>
<span class='text_page_counter'>(21)</span><div class='page_container' data-page=21>

Methamphetamine History



 Developed in late 1800s and used during


WWII to keep troops awake


 Given to pilots to enhance “performance”


 Used previously as diet aid, antidepressant,


stimulant, and drug of abuse



 Street names


 Speed, Krystal meth, Tina, Ice, Crank,


</div>
<span class='text_page_counter'>(22)</span><div class='page_container' data-page=22>

Management



</div>
<span class='text_page_counter'>(23)</span><div class='page_container' data-page=23></div>
<span class='text_page_counter'>(24)</span><div class='page_container' data-page=24>

Where did it come from?



 1960s: research into THC-like compounds


 Analgesic and anti-inflammatory minus


psychotropic effects


 Recognized as drugs of abuse in early 2000’s


in Europe


 Dr. JW Huffman researched THC analogues


for use in cancer and AIDS patients
 Developer of JWH compounds


</div>
<span class='text_page_counter'>(25)</span><div class='page_container' data-page=25>

What are they?



 Synthetic cannabinoids which work on the


CB1 and CB2 receptor like THC



 Marketed as herbal incense, herbal smoking


blends, potpourri, etc.


 Spice, K2, Mr. Nice Guy, Legal Funk, Tai Fun
 Misleading packaging


 Not for human consumption


 Commonly smoked


 New chemicals like PINACA and


</div>
<span class='text_page_counter'>(26)</span><div class='page_container' data-page=26>

Pharmacology



 Effects likely from mixture of herbs and actual


synthetic compounds


 Baybean, Beach bean, Dwarf skullcap, red clover,


vanilla, honey, wild dagga and more


 Affects CB1 and CB2 receptors found in


CNS/PNS


 Responsible for elevating mood, anxiety, cognition
 Responsible for reducing inflammation induced pain



</div>
<span class='text_page_counter'>(27)</span><div class='page_container' data-page=27>

Clinical Manifestation



 Most information from case reports and case


series


 Psychiatric effects predominate


 Anxiety, paranoia, agitation, delusions, and


psychosis


 Physical manifestations


 Tachycardia, HTN, diaphoresis, seizures, muscle


</div>
<span class='text_page_counter'>(28)</span><div class='page_container' data-page=28>

Management



 Agitated Delirium


 Like bath salts, unpredictable


 ABCs


 GI decontamination


 No antidote


 Supportive care



</div>
<span class='text_page_counter'>(29)</span><div class='page_container' data-page=29></div>
<span class='text_page_counter'>(30)</span><div class='page_container' data-page=30>

What are bath salts?



 Synthetic cathinone derivatives


 Synthesized as early as 1928 and studied for


medical use


 Methcathinone (1928)
 Mephedrone (1929)


 Used as antidepressant in 1930s in Soviet


Union


 Bupropion only cathinone with medical


</div>
<span class='text_page_counter'>(31)</span><div class='page_container' data-page=31>

Common Synthetic Cathinones and


Names



</div>
<span class='text_page_counter'>(32)</span><div class='page_container' data-page=32>

α-

<b>PVP</b>



 α-Pyrrolidinopentiophenone (also known as


α-pyrrolidinovalerophenone, α-PVP, O-2387,
β-keto-prolintane, prolintanone, or


desmethylpyrovalerone) “Flakka”


 Substituted cathinone & pyrrolidine



 Developed in the 1960s


 Heightened tactile enhancement


 Norepinephrine-dopamine reuptake inhibitor


</div>
<span class='text_page_counter'>(33)</span><div class='page_container' data-page=33>

Pharmacology



 β-ketonated amphetamines


 Ketone on β carbon leads to decreased CNS


penetration  increased doses  increased
effects


</div>
<span class='text_page_counter'>(34)</span><div class='page_container' data-page=34>

Clinical Manifestations


 Agitation (53.3%)


 Tachycardia (40%)
 Hypertension (20%)
 Seizures (20%)


 Palpitations (13.3%)


 Hallucinations/delusions
 Paranoia


 Renal failure



</div>
<span class='text_page_counter'>(35)</span><div class='page_container' data-page=35>

Management


 Protect yourself!


 Difficult to manage patients and unpredictable


behavior


 ABCs


 No antidote


 GI decontamination


 Benzodiazepines, barbiturates for agitation,


hallucinations and seizures


 Caution against using haloperidol


</div>
<span class='text_page_counter'>(36)</span><div class='page_container' data-page=36>

Loperamide & Diphenoxylate Abuse



 Inexpensive OTC anti-diarrheal with peripheral mu opioid


receptor activity


 200 - 400 tablets of Loperamide 2 mg daily
 Produces cardiac conduction abnormality


 QTc > 600 msec



 Normal up to 460


 High risk for TdP


 Mechanism of toxicity unknown


 Watch for patients purchasing MASSIVE quantities of


</div>
<span class='text_page_counter'>(37)</span><div class='page_container' data-page=37>

Other Common Drugs of Abuse


 Diphenhydramine


 Anticholinergic toxicity
 Lilliputian


hallucinations


 Physostigmine?


 DXM


 “Robotripping” or


“Triple C’s”


 Hallucinations and


euphoria


 Serotonin syndrome



 Nutmeg


 Contains myristicin
 Causes LSD-like


hallucinations


 Ingest grams


 Morning Glory Seeds


 Contains LSD-like


alkaloid


 Hallucinations
 N/V


</div>
<span class='text_page_counter'>(38)</span><div class='page_container' data-page=38></div>

<!--links-->

×